Company

Cutting-edge Japanese stem cell technology for a brighter future

About JENECELL

JENECELL drives innovation
in stem cell technology
to discover new ways to stay young.

As the Korean subsidiary of Alfresa Corporation, a major leading Pharmaceutical & Healthcare company
in Japan, JENECELL develops advanced products across pharmaceuticals, medical devices,
and cosmetics, including stem cell–based solutions.

Forever Young

Powered by cutting-edge science and breakthroughs in stem cell research, JENECELL delivers solutions that bring lasting vitality to human health. By building a comprehensive regenerative platform, JENECELL is leading innovation across the global biotechnology and healthcare markets.

Our Mission

To deliver groundbreaking
solutions based on science
and human stem cell technology
that improve quality
of life for all

Our Vision

To become a global leader
in the biotech and beauty industries
through an integrated
human stem cell technology platform

Our Vision
Core Values

Total Regenerative Platform

  • Integration

    Synergy between stem cell
    technology and global
    business strategy

  • Platform

    A comprehensive stem cell
    regeneration platform for
    continuous innovation

  • Leadership

    Growing into a global leader
    in business and biotechnology
    innovation

  • Global Expansion

    Delivering health and youth to
    people around the world through
    global expansion